Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents
Clinical trial NCT02946385 · COMPLETED
Trial details
- NCT number
- NCT02946385
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-15
- Primary completion
- 2018-02-13
- Enrollment
- 604
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.